Switch to:
More From Other Websites
Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q1, 2018 By the Numbers :... Sep 13 2017
Acasti Pharma Grants Stock Options Aug 31 2017
Neptune Technologies & Bioresources, Inc.: Price momentum supported by strong fundamentals Aug 18 2017
Neptune Announces the Election of its Directors Aug 17 2017
Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock Option Plan and Other... Aug 16 2017
Investor Network: Neptune Technologies & Bioressources Inc. to Host Earnings Call Aug 15 2017
Acasti Pharma Reports First Quarter FY 2018 Financial Results Aug 14 2017
Neptune Announces First Quarter Results Aug 14 2017
Neptune Announces Resignation of Pierre Fitzgibbon as a Director and the Appointment of John Moretz... Aug 08 2017
Neptune to Hold Conference Call to Discuss the Transaction with Aker BioMarine Aug 08 2017
Aker BioMarine and Neptune Announce Closing of $US34 Million Transaction to Accelerate Business and... Aug 08 2017
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under... Jul 28 2017
Neptune Receives Nasdaq Notification Regarding Minimum Bid Requirements Jul 27 2017
Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended... Jul 25 2017
Featured Company News - Opexa Therapeutics and Acer Therapeutics Announced Merger Agreement Followed... Jul 05 2017
CORRECTION: Acasti Pharma Grants Stock Options Jun 16 2017
Acasti Pharma To Present at Upcoming International Industry Conferences Jun 12 2017
Neptune Announces 4-Month Period and 13-Month Period Results Jun 07 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK